Education
About Us
Working with TipRanks
Follow Us
Concentra Group Holdings Parent, Inc. (CON)
NYSE:CON
CON Stock Chart & Stats
$21.91
$0.10(0.50%)
At close: 4:00 PM EST
$21.91
$0.10(0.50%)
Day’s Range― - ―
52-Week Range$18.55 - $24.69
Previous CloseN/A
Volume132.54K
Average Volume (3M)838.93K
Market Cap
$2.82B
Enterprise Value$4.84B
Total Cash (Recent Filing)$79.90M
Total Debt (Recent Filing)$2.10B
Price to Earnings (P/E)14.4
Beta0.51
Next Earnings
May 13, 2026EPS Estimate
0.33Next Dividend Ex-DateN/A
Dividend Yield1.27%
Share Statistics
EPS (TTM)0.28
Shares Outstanding128,634,750
10 Day Avg. Volume737,352
30 Day Avg. Volume838,933
Financial Highlights & Ratios
PEG Ratio2.08
Price to Book (P/B)6.34
Price to Sales (P/S)1.15
P/FCF Ratio12.65
Enterprise Value/Market Cap1.72
Enterprise Value/Revenue2.24
Enterprise Value/Gross Profit7.90
Enterprise Value/Ebitda11.84
Forecast
1Y Price Target
$28.60Price Target Upside30.53% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
EPS Forecast (FY)1.45
Revenue Forecast (FY)$2.31B
Bulls Say, Bears Say
Bulls Say
Cash Generation And Capital ReturnsAnalyst highlights strong cash-flow generation and recent share repurchases, signaling management confidence that can enhance per-share returns.
Earnings OutperformanceAnalyst points to an EBITDA beat driven by stronger margins, reinforcing the company's ability to deliver profit improvements above expectations.
Revenue Growth DriversManagement expects revenue growth to be driven by organic volume increases, pricing actions, known acquisitions, and planned clinic openings, supported by reported volume strength and a diversified payor mix.
Bears Say
Guidance ConservatismManagement's conservative guidance may limit near-term upside despite stronger reported operational results.
Investor Sentiment And VolatilityA pattern of cautious guidance alongside volume and margin beats may increase the risk of investor disappointment and higher share-price volatility.
Valuation SensitivityConservative guidance could dampen investor enthusiasm and constrain the stock's valuation multiple even with favorable operating metrics.
Concentra Group Holdings Parent, Inc. News
CON FAQ
What was Concentra Group Holdings Parent, Inc.’s price range in the past 12 months?
Concentra Group Holdings Parent, Inc. lowest stock price was $18.55 and its highest was $24.68 in the past 12 months.
What is Concentra Group Holdings Parent, Inc.’s market cap?
Concentra Group Holdings Parent, Inc.’s market cap is $2.82B.
When is Concentra Group Holdings Parent, Inc.’s upcoming earnings report date?
Concentra Group Holdings Parent, Inc.’s upcoming earnings report date is May 13, 2026 which is in 54 days.
How were Concentra Group Holdings Parent, Inc.’s earnings last quarter?
Concentra Group Holdings Parent, Inc. released its earnings results on Mar 09, 2026. The company reported $0.28 earnings per share for the quarter, beating the consensus estimate of $0.235 by $0.045.
Is Concentra Group Holdings Parent, Inc. overvalued?
According to Wall Street analysts Concentra Group Holdings Parent, Inc.’s price is currently Undervalued.
Does Concentra Group Holdings Parent, Inc. pay dividends?
Concentra Group Holdings Parent, Inc. pays a Quarterly dividend of $0.063 which represents an annual dividend yield of 1.27%. See more information on Concentra Group Holdings Parent, Inc. dividends here
What is Concentra Group Holdings Parent, Inc.’s EPS estimate?
Concentra Group Holdings Parent, Inc.’s EPS estimate is 0.33.
How many shares outstanding does Concentra Group Holdings Parent, Inc. have?
Concentra Group Holdings Parent, Inc. has 128,634,750 shares outstanding.
What happened to Concentra Group Holdings Parent, Inc.’s price movement after its last earnings report?
Concentra Group Holdings Parent, Inc. reported an EPS of $0.28 in its last earnings report, beating expectations of $0.235. Following the earnings report the stock price went down -0.578%.
Which hedge fund is a major shareholder of Concentra Group Holdings Parent, Inc.?
Currently, no hedge funds are holding shares in CON
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Concentra Group Holdings Parent, Inc. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$28.60 (30.53% Upside)
$28.60 (30.53% Upside)
Blogger Sentiment
Bullish
CON Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 766.3K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▲ 2.4%
Last 30 Days ▼ 8.7%
Last 30 Days ▼ 8.7%
Technicals
SMA
Positive
20 days / 200 days
Momentum
5.42%
12-Months-Change
Fundamentals
Return on Equity
46.60%
Trailing 12-Months
Asset Growth
12.57%
Trailing 12-Months
Company Description
Concentra Group Holdings Parent, Inc.
Concentra Group Holdings Parent, Inc. provides occupational health services in the United States. The company offers occupational and consumer health services, including workers' compensation injury care, urgent care, clinical testing, preventative care, and employer services, as well as wellness programs through occupational health centers and onsite clinics. It also provides Concentra Telemed, a telemedicine solution for the treatment of work-related injuries and illnesses, and employer services; pharmacy solution under the Concentra Pharmacy name; and Concentra Medical Compliance Administration, a third-party administrator that helps to manage abuse testing programs for employers with regulated or non-regulated workforces. The company was founded in 1979 and is based in Mechanicsburg, Pennsylvania. Concentra Group Holdings Parent, Inc. operates as a subsidiary of Select Medical Corporation.
CON Company Deck
CON Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed strong operational and financial momentum: double-digit headline revenue growth, meaningful volume and rate gains, adjusted EBITDA expansion, robust free cash flow and validation of clinical outcomes. Management also highlighted successful integration of acquisitions and a sizable de novo/M&A pipeline with a 2026 guidance band that targets continued growth and ~20% adjusted EBITDA margin. Offsetting factors include elevated investing activity and one-time integration/separation costs, a higher G&A run-rate from separation, increased financing costs and a net leverage ratio (3.4x) above the company target of ~3.0x. Organic growth excluding acquisitions was more moderate, and certain state reimbursement dynamics (e.g., New York) limit expansion opportunities until rates improve. On balance, positive operational execution and financial performance materially outweigh the near-term and transitional headwinds.View all CON earnings summariesCON Stock 12 Month Forecast
Average Price Target
$28.60
▲(30.53% Upside)
Technical Analysis
Labcorp Holdings
―
Envista Holdings
―
Safe Pro Group, Inc.
―
Flowco Holdings Inc Class A
―
Beta Bionics, Inc.
―
Ownership Overview
8.11% Insiders
32.39% Mutual Funds
12.52% Other Institutional Investors
23.35% Public Companies and
Individual Investors